1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNIH R34 Clinical Trial Planning Grant is sponsored by National Institutes of Health (NIH). Supports planning for clinical trials to evaluate interventions for diseases and conditions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Planning Grant (R34) | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health To provide support for the initial development of a clinical trial or research project, including the establishment of the research team; the development of tools for data management and oversight of the research; the development of a trial design or experimental research designs and other essential elements of the study or project, such as the protocol, recruitment strategies, procedure manuals and collection of feasibility data.
The NIH Planning Grant Program (R34) provides support for the initial development of a clinical trial or research project.
This program may support: establishment of the research team, development of tools for data management and research oversight development of a trial design or experimental research designs finalization of the protocol preparation of an operations/procedures manual pilot studies or collection of feasibility data for subsequent research projects* *When used as a planning grant for clinical trials, this program is not designed for the collection of preliminary data or the conduct of pilot studies to support the rationale for a clinical trial.
Renewal applications not allowed Project period limited to 3 years Direct costs limited to $225,000 per year and $450,000 over the 3-year project period Modular budgets required except for applications from foreign institutions Funding opportunity should define outcomes to be achieved by the end of the project period For a list of institutes and centers participating in the R34 program, see your funding opportunity.
For clinical trials, the planning grant is designed to: permit early peer review of the rationale and concept for the proposed clinical trial; support development of essential elements of a clinical trial lead to an application for support of a full-scale trial, based on elements developed under the planning period Standard Due Dates apply.
Standard Application Due Dates (when applicable) Participating Funding Organizations Each funding opportunity specifies the participating organizations. Applications must fit within the mission of at least one participating funding organization and meet all opportunity-specific requirements. The following funding organizations participate on at least one active funding opportunity.
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention Eunice Kennedy Shriver National Institute of Child Health and Human Development National Cancer Institute National Center for Complementary and Integrative Health National Heart, Lung, and Blood Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute of Nursing Research National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse Office of Behavioral and Social Sciences Research Office of Research on Women's Health Tribal Health Research Office U34 Planning Cooperative Agreement P20 Exploratory Grant (multicomponent) For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: Nonprofits, Universities, State/local governments, For-profits, Individuals. Confirm the full requirements in the official notice before applying.
The current listing shows up to $450,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
NIH R34 Clinical Trial Planning Grant is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article